ENDRA Life Sciences Inc. (NDRA)

USD 3.1

(-15.76%)

Total Liabilities Summary of ENDRA Life Sciences Inc.

  • ENDRA Life Sciences Inc.'s latest annual total liabilities in 2023 was 1.09 Million USD , down -47.08% from previous year.
  • ENDRA Life Sciences Inc.'s latest quarterly total liabilities in 2024 Q1 was 1.36 Million USD , up 24.41% from previous quarter.
  • ENDRA Life Sciences Inc. reported annual total liabilities of 2.06 Million USD in 2022, down -0.99% from previous year.
  • ENDRA Life Sciences Inc. reported annual total liabilities of 2.09 Million USD in 2021, up 31.01% from previous year.
  • ENDRA Life Sciences Inc. reported quarterly total liabilities of 1.36 Million USD for 2024 Q1, up 24.41% from previous quarter.
  • ENDRA Life Sciences Inc. reported quarterly total liabilities of 2.4 Million USD for 2023 Q3, up 3.99% from previous quarter.

Annual Total Liabilities Chart of ENDRA Life Sciences Inc. (2023 - 2014)

Historical Annual Total Liabilities of ENDRA Life Sciences Inc. (2023 - 2014)

Year Total Liabilities Total Liabilities Growth
2023 1.09 Million USD -47.08%
2022 2.06 Million USD -0.99%
2021 2.09 Million USD 31.01%
2020 1.59 Million USD -33.94%
2019 2.41 Million USD 147.86%
2018 974.58 Thousand USD 14.9%
2017 848.21 Thousand USD -38.74%
2016 1.38 Million USD 485.62%
2015 236.42 Thousand USD 142.23%
2014 97.6 Thousand USD 0.0%

Peer Total Liabilities Comparison of ENDRA Life Sciences Inc.

Name Total Liabilities Total Liabilities Difference
Aspira Women's Health Inc. 8.62 Million USD 87.305%
bioAffinity Technologies, Inc. 3.36 Million USD 67.467%
Intelligent Bio Solutions Inc. 5.59 Million USD 80.428%
Standard BioTools Inc. 159.86 Million USD 99.315%
Inotiv, Inc. 588.04 Million USD 99.814%
Prenetics Global Limited 44.01 Million USD 97.512%
Neuronetics, Inc. 81.64 Million USD 98.659%
Star Equity Holdings, Inc. 21.67 Million USD 94.947%
Castle Biosciences, Inc. 86.54 Million USD 98.735%
Psychemedics Corporation 6.59 Million USD 83.402%
RadNet, Inc. 2.07 Billion USD 99.947%
Exact Sciences Corporation 3.32 Billion USD 99.967%
IDEXX Laboratories, Inc. 1.77 Billion USD 99.938%
iSpecimen Inc. 6.07 Million USD 81.982%
OpGen, Inc. 13.44 Million USD 91.854%
Exagen Inc. 34.25 Million USD 96.802%
Bionano Genomics, Inc. 118.24 Million USD 99.074%
CareDx, Inc 223.28 Million USD 99.51%
Check-Cap Ltd. 1.33 Million USD 17.657%
Twist Bioscience Corporation 152.97 Million USD 99.284%
Guardant Health, Inc. 1.62 Billion USD 99.933%
Biodesix, Inc. 94.51 Million USD 98.841%
BioNexus Gene Lab Corp. 1.74 Million USD 37.13%
Precipio, Inc. 3.67 Million USD 70.175%
Natera, Inc. 691.79 Million USD 99.842%
Fulgent Genetics, Inc. 139.82 Million USD 99.217%
Sera Prognostics, Inc. 25.28 Million USD 95.668%
23andMe Holding Co. 206.64 Million USD 99.47%
OPKO Health, Inc. 622.47 Million USD 99.824%
Personalis, Inc. 95.65 Million USD 98.855%
Aclaris Therapeutics, Inc. 40.22 Million USD 97.277%
Applied DNA Sciences, Inc. 8.77 Million USD 87.525%
T2 Biosystems, Inc. 62.83 Million USD 98.257%
Neogen Corporation 1.44 Billion USD 99.924%
Myriad Genetics, Inc. 312.9 Million USD 99.65%
ICON Public Limited Company 7.74 Billion USD 99.986%
NeoGenomics, Inc. 739.69 Million USD 99.852%
Star Equity Holdings, Inc. 21.67 Million USD 94.947%
MDxHealth SA 121.92 Million USD 99.102%
Prenetics Global Limited 44.01 Million USD 97.512%
Illumina, Inc. 4.36 Billion USD 99.975%
DarioHealth Corp. 38.24 Million USD 97.136%
Medpace Holdings, Inc. 1.09 Billion USD 99.9%
Mainz Biomed B.V. 12.15 Million USD 90.994%
Trinity Biotech plc 83.38 Million USD 98.687%
Sotera Health Company 2.68 Billion USD 99.959%
bioAffinity Technologies, Inc. 3.36 Million USD 67.467%